Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Max Warncke
Characterization of the in Vitro and in Vivo Properties of CFZ533, a Blocking and Non-Depleting Anti-Cd40 Monoclonal Antibody
American Journal of Transplantation
Transplantation
Allergy
Immunology
Pharmacology
Control of the Specificity of T Cell-Mediated Anti-Idiotype Immunity by Natural Regulatory T Cells
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Related publications
199. A Non-Depleting Anti-Cd4 Monoclonal Antibody Suppressed Antibody Responses and Enhanced Efficacy From Gene Therapy in Pompe Disease
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Preclinical Antilymphoma Activity of a Humanized Anti-Cd40 Monoclonal Antibody, SGN-40
Cancer Research
Cancer Research
Oncology
Preparation and Characterization of Anti-Sulphamethoxazole (SMX) Monoclonal Antibody
Food and Agricultural Immunology
Immunology
Agronomy
Crop Science
Food Science
In Vivo Characterization in Non-Human Primates of the New Immune Suppressive Anti Human CD83 Monoclonal Antibody 3C12C That Prevents Graft Versus Host Disease
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
In Vitro and in Vivo Targeting Properties of Iodine-123- Or Iodine-131-Labeled Monoclonal Antibody 14C5 in a Non-Small Cell Lung Cancer and Colon Carcinoma Model
Clinical Cancer Research
Cancer Research
Oncology
T Cell Immunity to Lymphoma Following Treatment With Anti-Cd40 Monoclonal Antibody
Journal of Immunology
Allergy
Immunology
In Vitro Characterization of AA71, a Potent and Selective Human Monoclonal Antibody Against CGRP Receptor
Journal of Headache and Pain
Medicine
Neurology
Anesthesiology
Pain Medicine
Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody
Clinical Pharmacokinetics
Pharmacology
Comparative Studies of a Humanized Anti-Glycoprotein IIb/IIIa Monoclonal Antibody, YM337, and Abciximab on in Vitro Antiplatelet Effect and Binding Properties
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
